MAZZITELLI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.637
AS - Asia 849
EU - Europa 562
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 25
Totale 3.338
Nazione #
US - Stati Uniti d'America 1.598
SG - Singapore 366
IT - Italia 300
CN - Cina 171
BR - Brasile 127
VN - Vietnam 105
IN - India 76
DE - Germania 75
HK - Hong Kong 39
GB - Regno Unito 37
NL - Olanda 25
FI - Finlandia 24
SE - Svezia 21
CA - Canada 20
AR - Argentina 19
IQ - Iraq 17
BD - Bangladesh 14
CZ - Repubblica Ceca 13
RU - Federazione Russa 11
FR - Francia 10
MX - Messico 10
PL - Polonia 10
ES - Italia 9
CO - Colombia 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
PY - Paraguay 7
JP - Giappone 6
TR - Turchia 6
UA - Ucraina 6
VE - Venezuela 6
KE - Kenya 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
ID - Indonesia 4
CR - Costa Rica 3
LB - Libano 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
SA - Arabia Saudita 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.251
Città #
San Jose 334
Ashburn 190
Singapore 173
Chandler 126
Dallas 98
Santa Clara 75
Council Bluffs 57
Bengaluru 55
Hefei 55
Munich 51
Ho Chi Minh City 42
Hong Kong 36
Princeton 35
Beijing 33
Lawrence 33
Chicago 32
Hanoi 32
Milan 30
Los Angeles 28
London 23
New York 22
The Dalles 22
Phoenix 18
Rome 18
Turku 18
Wilmington 16
Boardman 14
São Paulo 14
Olomouc 13
Catanzaro 11
Atlanta 10
Baghdad 10
Palermo 10
San Francisco 10
Chennai 8
Montreal 8
Warsaw 8
Buffalo 7
Da Nang 7
Tashkent 7
Bari 6
Brooklyn 6
Des Moines 6
Helsinki 6
Orem 6
Rende 6
Boston 5
Cosenza 5
Nairobi 5
Porto Alegre 5
Tokyo 5
Biên Hòa 4
Denver 4
Hanover 4
Hải Dương 4
Johannesburg 4
Medellín 4
Monheim 4
Naples 4
Pisa 4
Redwood City 4
Rio de Janeiro 4
Settingiano 4
Toronto 4
Turin 4
Amsterdam 3
Asunción 3
Brasília 3
Buenos Aires 3
Caracas 3
Casavatore 3
Cascina 3
Clarksburg 3
Frankfurt am Main 3
Genoa 3
Jakarta 3
Manchester 3
Miami 3
Mumbai 3
Ricadi 3
Rosarno 3
San Nicola Manfredi 3
Seattle 3
Voghera 3
Acalanes Ridge 2
Ardea 2
Assago 2
Aversa 2
Badalona 2
Baku 2
Barcelona 2
Belo Horizonte 2
Borås 2
Casoria 2
Castelfiorentino 2
Catania 2
Cincinnati 2
Columbus 2
Dhaka 2
Dublin 2
Totale 1.995
Nome #
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 116
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 99
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 98
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 84
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 82
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 81
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 80
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 78
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 77
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 74
Evolving phenotypes of non-hospitalized patients that indicate long COVID 74
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 72
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 70
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 69
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 68
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 67
Therapy with RAS inhibitors during the COVID-19 pandemic 67
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 66
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 66
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 65
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 64
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 64
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 61
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 61
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 61
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 60
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 59
Outcome of hbv screening and vaccination in a migrant population in southern italy 57
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 57
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 56
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 56
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 55
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 54
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 54
Histopathology and immunophenotyping of late onset cutaneous manifestations of COVID-19 in elderly patients: Three case reports 54
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 52
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 50
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 49
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 49
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 49
Potential pitfalls in the use of real-world data for studying long COVID 48
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 48
Role of IgG and IgM and proinflammatory non-specific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 48
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 44
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 43
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 42
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy). 42
Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now? 41
Isavuconazole—animal data and clinical data 39
Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation 38
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 37
Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report. 37
Molecular characterization of Schistosoma infections in African migrants: Identification of a Schistosoma haematobium-bovis hybrid in bladder biopsies 37
On the use of clinical based infection data for pandemic case studies 34
The Role of the Microbiota Gut-Liver Axis during HCV Chronic Infection: A Schematic Overview 31
null 27
null 18
Eating Habits and Possible Effects of Mediterranean Diet on Body Composition in Ageing People Living with HIV in Two Italian Centres 9
Totale 3.338
Categoria #
all - tutte 27.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 0 18 4 4 23 22 6 12 29 3
2022/2023351 78 55 10 28 22 20 8 20 44 27 35 4
2023/2024231 46 30 8 24 25 46 5 8 0 2 16 21
2024/2025653 69 2 2 51 82 75 22 22 52 8 123 145
2025/20261.543 117 166 154 179 160 81 227 82 155 159 51 12
2026/2027324 13 67 198 46 0 0 0 0 0 0 0 0
Totale 3.338